Leica Biosystems Receives FDA Clearances for AI-Assisted Quality Control and Digital Pathology Scanners

Leica Biosystems enables faster cancer diagnoses through multiple digital pathology FDA clearances, including industry-first AI-assisted quality control software

Leica Biosystems introduces AI-driven quality control in digital pathology, streamlining workflows and enhancing diagnostic accuracy for better patient care.

Proscia Expands FDA-Cleared Digital Pathology Platform

PHILADELPHIA, PA — Proscia received a new U.S. Food and Drug Administration 510(k) clearance for its Concentriq AP-Dx digital pathology platform, expanding scanner compatibility and giving the company a regulatory …

Leica Biosystems Receives FDA Clearances for AI-Assisted Quality Control and Digital Pathology Scanners

The clearances include the first standalone software designed to automate quality control for digital pathology slides. Leica Biosystems announced multiple Food and Drug Administration (FDA) 510(k) clearances to expand its clinical digital pathology portfolio, including an artificial intelligence (AI)-assisted quality control software. The advancements aim to help laboratories manage increasing case volumes, staffing pressures, and diagnostic co…